We are live on ! Find out more
TVTX icon

Travere Therapeutics
TVTX

120 hedge funds and large institutions have $845M invested in Travere Therapeutics in 2017 Q4 according to their latest regulatory filings, with 17 funds opening new positions, 40 increasing their positions, 44 reducing their positions, and 10 closing their positions.

New
Increased
Maintained
Reduced
Closed

1,006% more call options, than puts

Call options by funds: $16.1M | Put options by funds: $1.45M

70% more first-time investments, than exits

New positions opened: 17 | Existing positions closed: 10

6% more funds holding

Funds holding: 113 → 120 (+7)

9% less repeat investments, than reductions

Existing positions increased: 40 | Existing positions reduced: 44

5.52% less ownership

Funds ownership: 107.54% → 102.02% (-5.5%)

18% less capital invested

Capital invested by funds: $1.03B → $845M (-$183M)

20% less funds holding in top 10

Funds holding in top 10: 5 → 4 (-1)

Holders
120
Holders Change
+7
Holders Change %
+6.19%
% of All Funds
2.72%
Holding in Top 10
4
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-20%
% of All Funds
0.09%
New
17
Increased
40
Reduced
44
Closed
10
Calls
$16.1M
Puts
$1.45M
Net Calls
+$14.6M
Net Calls Change
+$2.98M

Top Buyers

Rank Fund Capital Flow
1
Point72 Asset Management
Point72 Asset Management
Connecticut
+$8.96M
2
CCM
Consonance Capital Management
New York
+$3.17M
3
D.E. Shaw & Co
D.E. Shaw & Co
New York
+$3.1M
4
Ameriprise
Ameriprise
Minnesota
+$1.85M
5
State Street
State Street
Massachusetts
+$1.77M

Top Sellers

Rank Fund Capital Flow
1
Fidelity Investments
Fidelity Investments
Massachusetts
-$11.2M
2
Jennison Associates
Jennison Associates
New York
-$9.89M
3
ORI
Oak Ridge Investments
Illinois
-$5.66M
4
SFM
Sphera Funds Management
Israel
-$4.33M
5
Franklin Resources
Franklin Resources
California
-$3.63M
Name Holding Trade Value Shares
Change 		Change in
Stake
Citadel Advisors
26
Citadel Advisors
Florida
$7.55M -$1.2M -52,554 -13%
Geode Capital Management
27
Geode Capital Management
Massachusetts
$7.25M +$563K +24,615 +8%
SIM
28
Spark Investment Management
New York
$6.91M +$880K +38,500 +13%
D.E. Shaw & Co
29
D.E. Shaw & Co
New York
$6.21M +$3.1M +135,761 +85%
TC
30
Tavio Capital
New York
$6.19M – – –
Charles Schwab
31
Charles Schwab
California
$6.11M +$1.62K +71 +0%
T. Rowe Price Associates
32
T. Rowe Price Associates
Maryland
$6.03M -$1.38M -60,500 -17%
American Century Companies
33
American Century Companies
Missouri
$5.84M -$201K -8,784 -3%
IA
34
IPL Advisers
New York
$5.29M – – –
Prudential Financial
35
Prudential Financial
New Jersey
$4.79M +$753K +32,963 +17%
BA
36
Boston Advisors
Massachusetts
$4.28M -$134K -5,880 -3%
AllianceBernstein
37
AllianceBernstein
Tennessee
$4.22M +$571K +25,000 +14%
GKIM
38
GW&K Investment Management
Massachusetts
$4.01M +$1.26M +55,130 +41%
Bank of Montreal
39
Bank of Montreal
Ontario, Canada
$3.82M +$1.41M +61,634 +51%
Bank of America
40
Bank of America
North Carolina
$3.4M -$102K -4,462 -3%
JP Morgan Chase
41
JP Morgan Chase
New York
$2.83M +$48.1K +2,105 +2%
Ameriprise
42
Ameriprise
Minnesota
$2.34M +$1.85M +80,802 +269%
PP
43
PDT Partners
New York
$2.04M -$763K -33,391 -26%
Morgan Stanley
44
Morgan Stanley
New York
$1.94M -$752K -32,912 -26%
SCA
45
Secor Capital Advisors
New York
$1.87M +$457K +19,997 +29%
Fisher Asset Management
46
Fisher Asset Management
Washington
$1.85M +$280K +12,260 +16%
EU
47
Emory University
Georgia
$1.79M +$251K +10,968 +15%
Wells Fargo
48
Wells Fargo
California
$1.62M +$419K +18,314 +31%
TI
49
Telemetry Investments
New York
$1.27M +$442K +19,336 +47%
California State Teachers Retirement System (CalSTRS)
50
California State Teachers Retirement System (CalSTRS)
California
$1.27M -$19.2K -840 -1%
1
2
3 4 5

TVTX Hedge Fund Activity: Q4 2017 in Review

120 of the 4,409 institutional investors tracked by Wall St. Rank reported a position in Travere Therapeutics (TVTX) for Q4 2017, worth a combined $845M — down 18% from $1.03B a quarter earlier.

Buyers outnumbered sellers: 17 funds opened new TVTX positions and 10 closed out — a net gain of 7 holders — while 40 added to existing stakes and 44 trimmed.

The largest buyer was Point72 Asset Management, adding an estimated $8.96M. The largest seller was Fidelity Investments, cutting an estimated $11.2M.

  • 120 institutional investors held Travere Therapeutics (TVTX) as of Q4 2017, up from 113 in Q3 2017.
  • Funds reported $845M of Travere Therapeutics stock for Q4 2017, down 18% quarter-over-quarter.
  • 17 funds opened new Travere Therapeutics positions in Q4 2017 and 10 closed out, a net change of +7 holders.
  • The largest Travere Therapeutics buyer in Q4 2017 was Point72 Asset Management, an estimated $8.96M added.
  • The largest Travere Therapeutics seller in Q4 2017 was Fidelity Investments, an estimated $11.2M sold.

Based on aggregated 13F filings for Q4 2017.